ScoreWhy is ERIS Lifesciences Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 16.16% of over the last 5 years
2
Underperformed the market in the last 1 year
- Even though the market (BSE500) generated negative returns of -2.96% in the last 1 year, its fall in the stock was much higher with a return of -21.24%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is ERIS Lifescience for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
ERIS Lifescience
-21.06%
-0.71
29.89%
Sensex
-9.4%
-0.70
13.49%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
20.56%
EBIT Growth (5y)
16.16%
EBIT to Interest (avg)
12.66
Debt to EBITDA (avg)
1.80
Net Debt to Equity (avg)
0.59
Sales to Capital Employed (avg)
0.56
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
28.45%
Pledged Shares
16.85%
Institutional Holding
26.47%
ROCE (avg)
16.01%
ROE (avg)
16.48%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
37
Price to Book Value
4.59
EV to EBIT
23.53
EV to EBITDA
17.73
EV to Capital Employed
3.26
EV to Sales
6.25
PEG Ratio
0.41
Dividend Yield
0.56%
ROCE (Latest)
13.57%
ROE (Latest)
16.20%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
DEBT-EQUITY RATIO(HY)
Lowest at 0.60 times
OPERATING PROFIT TO INTEREST(Q)
Highest at 6.35 times
NET SALES(Q)
Highest at Rs 873.25 cr
PBDIT(Q)
Highest at Rs 296.22 cr.
PBT LESS OI(Q)
Highest at Rs 177.10 cr.
PAT(Q)
At Rs 142.39 cr has Grown at 20.7%
-4What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 7.13 times
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 67.30 cr
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.58 times
Loading Valuation Snapshot...
Here's what is working for ERIS Lifescience
Operating Profit to Interest - Quarterly
Highest at 6.35 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Debt-Equity Ratio - Half Yearly
Lowest at 0.60 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Sales - Quarterly
Highest at Rs 873.25 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 296.22 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 177.10 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 142.39 cr has Grown at 20.7%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for ERIS Lifescience
Inventory Turnover Ratio- Half Yearly
Lowest at 7.13 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 67.30 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Lowest at 4.58 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
